Variagenics: Zooming in on variety
Emerging Company Profile
Genetic variance in the population is a given. The question is how to apply that variance to drug development. Variagenics Inc.'s answer is to focus both on genetic variance in populations and on genetic differences between diseased and healthy tissue.
The company has developed a process that rapidly identifies genetic variants in a population and has applied the technology to narrowly defined drug discovery programs that exemplify the kinds of niche therapies that variance-based discovery - or pharmacogenomics - can